Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 21 - 30 of 77 Clinical Trials
ID/Name Source Type
Application of Amyloid PET in Cerebral Amyloid Angiopathy
NCT03542656 clinicaltrials.gov Clinical Trial
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
NCT01028053 clinicaltrials.gov Clinical Trial
Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07
NCT01447719 clinicaltrials.gov Clinical Trial
Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI)
NCT01812213 clinicaltrials.gov Clinical Trial
Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly
NCT00811122 clinicaltrials.gov Clinical Trial
Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volunteers
NCT00785759 clinicaltrials.gov Clinical Trial
Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)
NCT01607476 clinicaltrials.gov Clinical Trial
Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).
NCT01746706 clinicaltrials.gov Clinical Trial
Cerebral Amyloid Imaging Using Florbetapir (AV-45) for the Etiological Diagnosis of Poststroke Cognitive Impairment and Dementia
NCT02813434 clinicaltrials.gov Clinical Trial
Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
NCT01518374 clinicaltrials.gov Clinical Trial